Date

Time

3:30 pm

Assessing the Wellbeing of Women with Bleeding Disorders: 
Focus on Bone and Mental Health

A live virtual educational activity

Date: Monday, June 30, 2025
Time: 3:30pm-4:30pm EST

Jointly provided by Partners for Advancing Clinical Education  
and the National Bleeding Disorders Foundation

Partners for Advacning Clinical Education
National Bleeding Disorders Foundation

 

Target Audience

This activity is intended for U.S. physicians, physician assistants, osteopaths, and nurse practitioners who care for women with inherited bleeding disorders.

Educational Objectives

At the conclusion of this activity, the participants should be better able to:

  • Describe the need for regular screening of health in women with bleeding disorders
  • Review data outcomes from a recent study among U.S. HTCs on screening for bone health in women with bleeding disorders
  • Discuss a few of the more commonly prescribed drugs available to treat anxiety and depression and any potential implications specific to individuals with bleeding disorders.
  • Explain the need for hematologists and other healthcare providers to raise questions about an individual’s mental health and wellness during HTC visits.

Faculty

Meera Chitlur, MD  
Barnhart-Lusher Hemostasis Research Endowed Chair 
Professor of Pediatrics  
Wayne State University  
Children’s Hospital of Michigan  
Detroit, Michigan

Divyaswathi Citla-Sridhar, MD  
Assistant Professor of Pediatrics  
Associate Director, Arkansas Center for Bleeding Disorders 
Arkansas Children’s Hospital  
University of Arkansas for Medical Sciences  
Little Rock, Arkansas 

Nathan Connell, MD, MPH, FACP 
Chief of Medicine, Brigham and Women's Faulkner Hospital  
Vice Chair of Medicine for BWFH Clinical Services and Education  
Associate Director, Boston Hemophilia Center  
Associate Professor of Medicine, Harvard Medical School  
Boston, Massachusetts

Disclosure of Conflicts of Interest

Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners’ policies.

Agenda

3:30 pm – 3:40 pm     Welcome and pre-test   

3:40 pm – 3:55 pm     Case study 1 

3:55 pm – 4:05 pm     Presentation of study data 

4:05 pm – 4:20 pm     Case study 2 

4:20 pm – 4:30 pm     Discussion/Q&A and post-test

Fee Information

There is no fee for this educational activity.

Joint Accreditation Statement

Jointly Accredited Provider LogoIn support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and NBDF. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $500,000 with 100 percent funded by CDC/HHS. The contents are solely those of the author(s) and do not necessarily represent the official views, nor an endorsement, by CDC/HHS or the U.S. Government.

Register

&nsbp;

&nsbp;